Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0

Posted on By

BA-BE Studies: SOP for Meal Composition and Timing for Fed Studies – V 2.0

Standard Operating Procedure for Meal Composition and Timing for Fed Studies in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/061/2025
Supersedes SOP/BA-BE/061/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the process for determining, preparing, and timing the standardized high-fat, high-calorie meals administered before drug dosing in fed state Bioavailability/Bioequivalence (BA/BE) studies, ensuring consistency across all subjects and study periods.

2. Scope

This SOP applies to all fed BA/BE studies conducted at the clinical research unit, including the dietitian, study coordinator, and clinical team involved in meal planning, preparation, and supervision of consumption.

3. Responsibilities

  • Study Dietitian: Plans and prepares the meal as per regulatory calorie and fat requirements.
  • Clinical Research Coordinator: Ensures adherence to meal timing and documents intake.
  • Ward Staff: Supervises meal consumption and records compliance in logs.
See also  BA-BE Studies: SOP for Administration of Study Drug in Fasted State - V 2.0

4. Accountability

The Principal Investigator is accountable for ensuring that all subjects receive the standardized meal within the specified time frame prior to drug administration.

5. Procedure

5.1 Meal Composition Requirements

  1. Design a standardized high-fat, high-calorie breakfast with:
    • Total Calories: 800–1000 kcal
    • Fat Content: At least 50% of total calories
    • Carbohydrates: Approximately 30%
    • Protein: Approximately 20%
  2. Typical food items may include eggs, buttered toast, sausages, hash browns, and full-fat milk or milkshake.
  3. Record the meal composition in Annexure-1: Fed Meal Nutritional Breakdown Sheet.

5.2 Meal Preparation

  1. Ensure ingredients are weighed and recorded for consistency.
  2. Prepare the meal freshly on the day of dosing.
  3. Ensure temperature and hygiene controls are followed in the preparation area.

5.3 Meal Serving and Timing

  1. Start serving the standardized meal exactly 30 minutes before the planned dosing schedule.
  2. Each subject must complete the meal within 30 minutes of serving.
  3. Supervise and document the time of meal start and end for each subject in Annexure-2: Meal Consumption Log.
See also  BA-BE Studies: SOP for IMP Accountability Logs - V 2.0

5.4 Monitoring Compliance

  1. Observe subjects during meal consumption to ensure complete intake.
  2. Record any leftover food or refusal in Annexure-3: Meal Deviation Log.
  3. Subjects who fail to consume the meal as required should be reported to the PI for further action.

5.5 Quality Control of Meals

  1. Cross-check the nutritional value using validated nutritional software or manual calculation.
  2. File a certificate of meal composition with the study documentation.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • PI: Principal Investigator
  • CRC: Clinical Research Coordinator

7. Documents

  1. Fed Meal Nutritional Breakdown Sheet – Annexure-1
  2. Meal Consumption Log – Annexure-2
  3. Meal Deviation Log – Annexure-3

8. References

  • US FDA Guidance: Food-Effect Bioavailability and Fed Bioequivalence Studies
  • ICH E6(R2) – Good Clinical Practice
  • Study-Specific Protocol
See also  BA-BE Studies: SOP for Dispensing of Investigational Medicinal Product (IMP) - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Fed Meal Nutritional Breakdown Sheet

Meal Item Quantity Calories (kcal) Fat (g) Carbs (g) Protein (g)
Omelette 2 eggs 180 15 2 12
Buttered Toast 2 slices 240 12 24 4
Milkshake 250 mL 350 18 30 8

Annexure-2: Meal Consumption Log

Subject ID Meal Start Time Meal End Time Compliance Remarks
VOL-061 07:00 07:28 Yes Meal completed

Annexure-3: Meal Deviation Log

Subject ID Issue Reported To Action Taken Date
VOL-061X Left 25% of food Dr. Arvind Shah Excluded from dosing 17/04/2025

Revision History:

Revision Date Revision No. Details Reason Approved By
15/01/2022 1.0 Initial Release New SOP Implementation QA Head
17/04/2025 2.0 Added nutritional breakdown and deviation handling Protocol alignment and audit compliance QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Biosimilars: SOP for Agarose Gel Electrophoresis – V 2.0
Next Post: Aerosol: SOP for Retrospective Validation of Aerosol Manufacturing Processes – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version